Manufacturing & Supply Chain

AbbVie announces a €60 million expansion as company’s Cork facility marks 20th anniversary

 Breaking News

AbbVie announces a €60 million expansion as company’s Cork facility marks 20th anniversary

AbbVie announces a €60 million expansion as company’s Cork facility marks 20th anniversary
September 27
09:59 2022
Spread the love

AbbVie, a global research and development-based biopharmaceutical company with a significant presence across eight Irish locations, has announced a €60 million investment at its manufacturing site in Cork. The expansion, which will include the development of a new state-of-the-art facility, will create approximately 70 new jobs. New technologies will be introduced to the site in Carrigtwohill which will allow it to support AbbVie’s aesthetics business.

AbbVie will also leverage the expansion to introduce new technology and upgrades that will improve the carbon footprint of the wider Cork site. Construction will commence in 2023 with manufacturing operations scheduled to begin in 2025.

In addition to the multimillion-euro investment announced today, AbbVie is also embarking on a three-year strategic training programme at the Carrigtwohill facility. The initiative is supported by the Government through the IDA and will enhance and develop key workforce skills to support incoming new technologies.

The Carrigtwohill plant celebrates its 20th anniversary in November and currently employs approximately 150 people. The €60 million announcement brings AbbVie’s total investment at the location since the company’s inception in 2013 to approximately €177 million.

Commenting on the announcement Malcolm Garde, Site Director, AbbVie Cork, said: “This latest investment is a fantastic opportunity for the Cork site and a recognition of the expertise and commitment of our dedicated employees over the past 20 years. The expansion and associated cutting-edge technologies will help us to further develop our employees and attract new skilled talent.”

IDA Ireland CEO Martin Shanahan said: “This latest investment by AbbVie is testament to Ireland being an attractive and supportive location for continued investment by established companies. Marking two decades of successful operations at its manufacturing site in Carrigtwohill by making a further €60 million investment, creating 70 additional jobs, is a strong endorsement and demonstrates a clear commitment to the company’s Cork site.”

The 70 new roles will be spread across various areas including sterile manufacturing, quality control, and engineering. To explore opportunities to join the AbbVie team in Carrigtwohill, visit https://careers.abbvie.com/en 

AbbVie employs approximately 2,600 people at seven other locations across Ireland including Sligo, Mayo, and Dublin. The company has been recognised as one of the Best Large Workplaces in Ireland for the past nine years and was named as a Best Workplace for Women earlier this year. AbbVie was also named ‘Biopharma Company of the Year’ at the most recent Irish Pharma Industry Awards.

CAPTION:

Pictured (L-R): Malcolm Garde, Site Director, AbbVie Cork; Azita Saleki-Gerhardt, Executive VP Operations, AbbVie; and Michael Lohan, Head of Life Science, Engineering and Industrial Technology at IDA Ireland.


Warning: count(): Parameter must be an array or an object that implements Countable in /home/manufacturingsup/public_html/wp-content/themes/legatus-theme/includes/single/post-tags.php on line 5

About Author

mike

mike

Related Articles



 

New Subscriber

    Subscribe Here



    Advertisements
















    National Manufacturing Conference & Exhibition 2020

    NIBRT Springboard Success Stories